A04495 Summary:

BILL NOA04495
 
SAME ASNo Same As
 
SPONSORMontesano (MS)
 
COSPNSR
 
MLTSPNSRMcDonough
 
Add §3346, Pub Health L
 
Requires a doctor to obtain the informed consent of patients prior to prescribing psychiatric drugs notifying the patients of possible adverse effects of the drug.
Go to top    

A04495 Actions:

BILL NOA04495
 
02/04/2019referred to higher education
01/08/2020referred to higher education
07/14/2020held for consideration in higher education
Go to top

A04495 Committee Votes:

HIGHER EDUCATION Chair:Glick DATE:07/14/2020AYE/NAY:18/7 Action: Held for Consideration
GlickAyeSmithNay
GottfriedAyeFitzpatrickNay
EnglebrightAyeGarbarinoNay
CahillAyeAshbyNay
LiftonAyeReillyNay
CusickAyeSalkaNay
LupardoAyeWalczykNay
StirpeAye
FahyAye
PichardoAye
SimonAye
McDonaldAye
BichotteAye
HyndmanAye
EpsteinAye
GriffinAye
McMahonAye
ButtenschonAye

Go to top

A04495 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A04495 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          4495
 
                               2019-2020 Regular Sessions
 
                   IN ASSEMBLY
 
                                    February 4, 2019
                                       ___________
 
        Introduced by M. of A. MONTESANO -- Multi-Sponsored by -- M. of A. McDO-
          NOUGH -- read once and referred to the Committee on Higher Education
 
        AN  ACT to amend the public health law, in relation to requiring notifi-
          cation and the informed consent of the patient  prior  to  prescribing
          psychiatric drugs

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The public health law is amended by adding  a  new  section
     2  3346 to read as follows:
     3    §  3346.  Psychiatric drug informed consent. No doctor shall prescribe
     4  an antipsychotic, antidepressant, hallucinogen, or mood stabilizer drug,
     5  brand or generic, as defined in section thirty-three hundred six of this
     6  article, for the treatment of psychiatric disorders or conditions  with-
     7  out  the  prior  notification  and  the  signed  informed consent of the
     8  patient informing the patient of any possible  adverse  effects  of  the
     9  drug and the interaction with other medications the patient is currently
    10  prescribed.
    11    § 2. This act shall take effect immediately.
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD08263-01-9
Go to top